Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
A few weeks ago, McDermott + Bull Interim Leaders and I hosted a small breakfast for C-Level executives in the life sciences sector. Simon Arkell, CEO and Co-Founder of Ryght AI, joined us as our keynote speaker to share his thoughts and insights on AI and its impact...
For many organizations, partnering with an executive search firm can feel a bit like trusting a stranger with the keys to your success. Partnering with a search firm should be built on a foundation of trust, respect, mutual understanding, and collaboration. In this...
As we reflect on the dynamic year of 2023 in the executive talent industry, it’s evident that the landscape was shaped by various economic and demographic shifts. It began with increasing interest rates to combat inflation, leading to what some analysts term a...
Recently, my colleague Mark McConnell and I hosted a breakfast meeting with around 40 local C-Suite executives within the life sciences sector. Paul LaViollette, Managing Partner and Chief Operating Officer of SV Health Investors, joined us from Boston to share his...
A Forbes Report Prepared by Forbes Coaches Council. To read the full article on Forbes.com, click here. At McDermott + Bull Interim Leaders, we help clients deal with the unexpected departure of key executives every day. This can be an incredibly disruptive...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
